Active, Not Recruiting
Safety, Tolerability, and Pharmacokinetics (PK) of Single and Multiple Ascending Oral Doses of iQ-007
NCT06899230
- Conditions
- Brain Diseases, Central Nervous System Diseases, Drug Resistant Epilepsy, +7 more
- Locations
-
- CMAX Clinical Research Pty Ltd Adelaide, South Australia, Australia